España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Krystal Biotech
KRYS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$187.86
5.24
2.87%
At close: -
$187.86
0.00
0.00%
After Hours: 4:02 PM EDT
Get Report
Comment
Q4 2024 Earnings were released on Wed Feb 19th, before the market open
The most recent conference call was at 8:30 AM, 2 days ago
Click to view past webcast
Krystal Biotech (KRYS) Forecast
News
Earnings
Krystal Biotech (KRYS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Krystal Biotech (NASDAQ:KRYS) Stock
Krystal Biotech Stock (NASDAQ: KRYS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, February 20, 2025
A Glimpse Into The Expert Outlook On Krystal Biotech Through 9 Analysts
Benzinga Insights
Citigroup Maintains Neutral on Krystal Biotec...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Kr...
Benzinga Newsdesk
Krystal Biotech shares are trading higher aft...
Benzinga Newsdesk
Chardan Capital Maintains Buy on Krystal Biot...
Benzinga Newsdesk
Wednesday, February 19, 2025
HC Wainwright & Co. Reiterates Buy on Krystal...
Benzinga Newsdesk
Krystal Biotech shares are trading higher aft...
Benzinga Newsdesk
Krystal Biotech Q4 2024 GAAP EPS $1.52 Beats ...
Benzinga Newsdesk
Earnings Scheduled For February 19, 2025
Benzinga Insights
Tuesday, February 11, 2025
Looking Into Krystal Biotech's Recent Short Interest
Benzinga Insights
Tuesday, January 21, 2025
(KRYS) - Analyzing Krystal Biotech's Short Interest
Benzinga Insights
Monday, January 20, 2025
Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years
Benzinga Insights
Monday, January 06, 2025
Here's How Much $1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today
Benzinga Insights
Wednesday, December 18, 2024
Here's How Much $100 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today
Benzinga Insights
Chardan Capital Maintains Buy on Krystal Biot...
Benzinga Newsdesk
Krystal Biotech Announces Initial Results Fro...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Krystal...
Benzinga Newsdesk
Friday, December 13, 2024
HC Wainwright & Co. Reiterates Buy on Krystal...
Benzinga Newsdesk
Thursday, December 12, 2024
Expert Ratings For Krystal Biotech
Benzinga Insights
Chardan Capital Maintains Buy on Krystal Biot...
Benzinga Newsdesk
Krystal Biotech Announces Initial Clinical Up...
Benzinga Newsdesk
Tuesday, December 10, 2024
HC Wainwright & Co. Reiterates Buy on Krystal...
Benzinga Newsdesk
Monday, December 09, 2024
Krystal Biotech Provides Update On EMA's Ongo...
Benzinga Newsdesk
Tuesday, November 05, 2024
Citigroup Maintains Neutral on Krystal Biotec...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Krystal...
Benzinga Newsdesk
Monday, November 04, 2024
Krystal Biotech Q3 2024 GAAP EPS $0.91 Beats ...
Benzinga Newsdesk
Wednesday, October 30, 2024
$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today
Benzinga Insights
Friday, October 11, 2024
$100 Invested In Krystal Biotech 5 Years Ago Would Be Worth This Much Today
Benzinga Insights
Monday, October 07, 2024
Exelixis Gains 20.7% in Three Months: Is This the Right Time to Buy?
Zacks
Wednesday, October 02, 2024
IONS' Rare Neurology Disorder Candidate Gets FDA's Fast Track Tag
Zacks
Friday, September 27, 2024
SAGE, BIIB End Collaboration for Neurology Candidate SAGE-324
Zacks
Wednesday, September 25, 2024
$1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth This Much Today
Benzinga Insights
Tuesday, September 24, 2024
BHVN Stock Up as Rare Neurological Disease Study Meets Primary Goal
Zacks
Friday, September 20, 2024
VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis
Zacks
Friday, September 13, 2024
FULC Stock Falls as Muscle Disorder Study Misses Primary Goal
Zacks
Thursday, September 12, 2024
Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years
Benzinga Insights
Wednesday, September 11, 2024
Krystal Biotech shares are trading higher aft...
Benzinga Newsdesk
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
Stifel Maintains Buy on Krystal Biotech, Rais...
Benzinga Newsdesk
Tuesday, September 10, 2024
How Is The Market Feeling About Krystal Biotech?
Benzinga Insights
Monday, September 09, 2024
IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab
Zacks
Friday, September 06, 2024
FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up
Zacks
Tuesday, September 03, 2024
ALNY Down Despite Positive Data From Heart Disease Drug Study
Zacks
Thursday, August 29, 2024
Cantor Fitzgerald Reiterates Overweight on Kr...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Krystal...
Benzinga Newsdesk
Wednesday, August 28, 2024
HC Wainwright & Co. Maintains Buy on Krystal ...
Benzinga Newsdesk
Here's How Much $1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today
Benzinga Insights
Jeune Aesthetics, Subsidiary Of Krystal Biote...
Benzinga Newsdesk
Monday, August 12, 2024
Evercore ISI Group Maintains Outperform on Kr...
Benzinga Newsdesk
Friday, August 09, 2024
Here's How Much $1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
